NCT05503316

Brief Summary

Persons with an injury of the central nervous system clearly experience motor impairments. Among the most commonly described consequences are gait abnormalities and impaired balance. Although these are undeniably linked, they are also influenced by other factors. A recent systematic review (Xie, 2022) reports impaired balance, the presence of depression or anxiety, and decreased function of the lower limbs as important risk factors for fear of falling in persons after a stroke. Also for people with a spinal cord injury, the fear of falling has a major impact on their level of participation and quality of life (Sing, 2021). Preventing falls and reducing fear of falling is an important part of neurological rehabilitation programs as it is known that fear of falling has a negative impact on the patient's activity level. This in turn will lead to an increased risk of falling and a negative effect on neurological recovery due to insufficiently practicing their balance while walking. Since 2019 the rehabilitation center of UZ gent offers GRAIL training. This device aims to train walking balance and gait adaptability in a virtual environment. Patients who are admitted and/or undergoing ambulatory rehabilitation at UZ Gent are given the opportunity to complete a 5-week training schedule on the GRAIL. Before and after this training intervention period, the investigators evaluate the gait pattern of these patients. After the training period, the patients also complete a questionnaire about their experience while training on the GRAIL and often also indicate that they become more confident in their own balance when walking. That is why the researchers now also want to measure this. Research questions:

  1. 1.Do people with high confidence in their balance when walking differ from those with low confidence in their balance when walking?
  2. 2.Does GRAIL training have a different effect on confidence in balance than traditional rehabilitation? To answer the 2nd research question, patients who follow the traditional rehabilitation (control group) also receive the same tests as the people who follow GRAIL training.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
42

participants targeted

Target at P50-P75 for not_applicable stroke

Timeline
Completed

Started Sep 2022

Typical duration for not_applicable stroke

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 4, 2022

Completed
12 days until next milestone

First Posted

Study publicly available on registry

August 16, 2022

Completed
20 days until next milestone

Study Start

First participant enrolled

September 5, 2022

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 1, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

September 1, 2024

Completed
Last Updated

September 13, 2023

Status Verified

September 1, 2023

Enrollment Period

2 years

First QC Date

August 4, 2022

Last Update Submit

September 12, 2023

Conditions

Outcome Measures

Primary Outcomes (19)

  • Gait speed (m/s)

    Difference in gait speed between persons with high balance confidence and low balance confidence measured during walking on the treadmill.

    Before the intervention

  • Step length (m)

    Step length (m) * Difference in spatiotemporal parameters between persons with high balance confidence and persons with low balance confidence (measured before intervention). * Difference in spatiotemporal parameters during normal walking and during a balance task during walking (measured before and after intervention period) * Difference in spatiotemporal parameters during normal walking before and after intervention.

    Before intervention

  • Step width (m)

    Step width (m) * Difference in spatiotemporal parameters between persons with high balance confidence and persons with low balance confidence (measured before intervention). * Difference in spatiotemporal parameters during normal walking and during a balance task during walking (measured before and after intervention period) * Difference in spatiotemporal parameters during normal walking before and after intervention.

    Before intervention

  • Cadence (steps per minute)

    Cadence (steps per minute) * Difference in spatiotemporal parameters between persons with high balance confidence and persons with low balance confidence (measured before intervention). * Difference in spatiotemporal parameters during normal walking and during a balance task during walking (measured before and after intervention period) * Difference in spatiotemporal parameters during normal walking before and after intervention.

    Before intervention

  • Cadence (steps per minute)

    Cadence (steps per minute) * Difference in spatiotemporal parameters between persons with high balance confidence and persons with low balance confidence (measured before intervention). * Difference in spatiotemporal parameters during normal walking and during a balance task during walking (measured before and after intervention period) * Difference in spatiotemporal parameters during normal walking before and after intervention.

    Within one week after the intervention

  • Time in swing and stance phase (s)

    Time in swing and stance phase (s) * Difference in spatiotemporal parameters between persons with high balance confidence and persons with low balance confidence (measured before intervention). * Difference in spatiotemporal parameters during normal walking and during a balance task during walking (measured before and after intervention period) * Difference in spatiotemporal parameters during normal walking before and after intervention.

    Before intervention

  • Time in swing and stance phase (s)

    Time in swing and stance phase (s) * Difference in spatiotemporal parameters between persons with high balance confidence and persons with low balance confidence (measured before intervention). * Difference in spatiotemporal parameters during normal walking and during a balance task during walking (measured before and after intervention period) * Difference in spatiotemporal parameters during normal walking before and after intervention.

    Within one week after the intervention

  • Step width (m)

    step width (m) * Difference in spatiotemporal parameters between persons with high balance confidence and persons with low balance confidence (measured before intervention). * Difference in spatiotemporal parameters during normal walking and during a balance task during walking (measured before and after intervention period) * Difference in spatiotemporal parameters during normal walking before and after intervention.

    Within one week after the intervention

  • Step length (m)

    Step length (m) * Difference in spatiotemporal parameters between persons with high balance confidence and persons with low balance confidence (measured before intervention). * Difference in spatiotemporal parameters during normal walking and during a balance task during walking (measured before and after intervention period) * Difference in spatiotemporal parameters during normal walking before and after intervention.

    Within one week after the intervention

  • 10 meter walk test

    Difference in gait speed between persons with high balance confidence and low balance confidence measured during walking overground. Change in overground walking speed before and after intervention.

    Before intervention

  • 10 meter walk test

    Difference in gait speed between persons with high balance confidence and low balance confidence measured during walking overground. Change in overground walking speed before and after intervention.

    Within one week after the intervention

  • Margins of stability

    Dynamic balance during walking measured during normal walking and during the balance task.

    Before intervention

  • Margins of stability

    Dynamic balance during walking measured during normal walking and during the balance task.

    Within one week after the intervention

  • Activity-specific Balance Confidence (ABC) scale

    Balance confidence scored by the participant (questionnaire) per item (16 items) geeft participant weer hoeveel vertrouwen hij heeft in dit item (0-100%) Hogere score is meer vertrouwen.

    Before intervention

  • Activity-specific Balance Confidence (ABC) scale

    Balance confidence scored by the participant (questionnaire) per item (16 items) geeft participant weer hoeveel vertrouwen hij heeft in dit item (0-100%) Hogere score is meer vertrouwen.

    Within one week after the intervention

  • Visual analogue scale score to assess task specific confidence

    Participants are asked to score the level of confidence that they have that they can complete the balance task (score 0-10). Higher score is more confidence.

    Before intervention

  • Visual analogue scale score to assess task specific restraints

    Participants are asked to score the level of restraint that they have to complete the balance task due to fear of falling (score 0-10). Higher score is more restraint.

    Before intervention

  • Visual analogue scale score to assess task specific confidence

    Participants are asked to score the level of confidence that they have that they can complete the balance task (score 0-10). Higher score is more confidence.Participants are asked to score the level of restraint that they have to complete the balance task due to fear of falling (score 0-10).

    Within one week after the intervention

  • Visual analogue scale score to assess task specific restraints

    Participants are asked to score the level of restraint that they have to complete the balance task due to fear of falling (score 0-10). Higher score is more restraint.

    Within one week after the intervention

Secondary Outcomes (6)

  • Quality of life using the SF36_C questionnaire

    Before intervention

  • Quality of life using the SF36_C questionnaire

    Within one week after the intervention

  • Anxiety and depression

    Before intervention

  • Anxiety and depression

    Within one week after the intervention

  • Gait quality

    Within one week after the intervention

  • +1 more secondary outcomes

Study Arms (2)

GRAIL group

EXPERIMENTAL

Participants will receive 5 weeks of training on the GRAIL device, which is focused on training balance during walking. Therapy frequency: 2\*30 minutes per week.

Other: Dynamic balance training

Traditional gait rehabilitation

ACTIVE COMPARATOR

Participant will receiver traditional gait rehabilitation which also includes training balance during walking. Therapy frequency in both groups is equal.

Other: Traditional gait rehabilitation

Interventions

Participants will receive dynamic balance training while walking on the GRAIL device.

GRAIL group

Participants will receive traditional gait rehabilitation that also includes balance training while walking but not on the GRAIL device.

Traditional gait rehabilitation

Eligibility Criteria

Age18 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Persons who are admitted to the rehabilitation center of the Ghent University Hospital (in and outpatient) and suffered a stroke, spinal cord injury of traumatic brain injury
  • Persons have to be able to walk for at least 6 minutes without the need of a person to help and with minimal help of a walking device. (level FAC 2 or higher)
  • Participants who understand orders during the assessment and intervention.

You may not qualify if:

  • Other neurological conditions (MS, Parkinson, ...)
  • Orthopedic trauma or recent acute trauma that influence walking ability.
  • Body weight exceeds 120 kg.
  • Severe dizziness that makes it impossible to practice in standing position.
  • Cardiac or pulmonary problems that require monitoring during exercising.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Ghent University Hospital

Ghent, 9000, Belgium

RECRUITING

MeSH Terms

Conditions

StrokeSpinal Cord InjuriesBrain Injuries, Traumatic

Condition Hierarchy (Ancestors)

Cerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular DiseasesSpinal Cord DiseasesTrauma, Nervous SystemWounds and InjuriesBrain InjuriesCraniocerebral Trauma

Study Officials

  • Anke Van Bladel, PhD

    Ghent University Hopsital / Ghent University

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Anke Van Bladel, Phd

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 4, 2022

First Posted

August 16, 2022

Study Start

September 5, 2022

Primary Completion

September 1, 2024

Study Completion

September 1, 2024

Last Updated

September 13, 2023

Record last verified: 2023-09

Locations